The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients
Anna C. H. Willemsen(Maastricht University Medical Centre), Annemie M.W.J. Schols(Maastricht University), Mari F.C.M. van den Hout(Erasmus MC Cancer Institute), Laura W. J. Baijens(Maastricht University Medical Centre), Nina De Moor(VIB-KU Leuven Center for Cancer Biology), Esther Hauben(Universitair Ziekenhuis Leuven), Michel Bila(Universitair Ziekenhuis Leuven), Ann Hoeben(Maastricht University Medical Centre), Paul M. Clément(Universitair Ziekenhuis Leuven), Vincent Vander Poorten(KU Leuven), Jeroen Van Dessel(Universitair Ziekenhuis Leuven)
Cited by 24
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2006|2k
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|1998|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary Rehabilitation
|American Review of Respiratory Disease|1993|725